REG - Genus - Director/PDMR Shareholding
12/09/2024 17:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240912:nRSL0238Ea&default-theme=true
RNS Number : 0238E Genus PLC 12 September 2024
12 September 2024
Genus plc
Director/PDMR Shareholding
Genus plc (LSE: GNS) announces that on 11 September 2024, conditional nil-cost
share options were granted under the Genus 2019 Performance Share Plan ('PSP')
over ordinary shares in Genus to the Executive Directors and members of the
Genus Executive Leadership Team ('GELT') as listed in table A below. In
addition, following Genus's compulsory deferral requirements relating to the
annual bonus earned by Executive Directors and GELT for the financial year
ended 30 June 2024, nil-cost share options were granted over ordinary shares
under the Genus 2019 Deferred Share Bonus Plan ('DSBP') as listed in table B
below.
Details of the performance conditions that apply to the nil-cost share options
can be found in the Directors' Remuneration Report of the Genus 2024 Annual
Report which will be published next month.
The price at which PSP and DSBP nil-cost share options have been granted was
determined in accordance with the PSP and DSBP rules.
Genus further announces that, further to the vesting on 14 September 2023 of
conditional nil-cost options granted in 2020 under the PSP, as listed in table
C below; and conditional nil-cost options granted in 2020 under the DSBP as
listed in table D below, Elena Rice, Chief Scientific Officer sold ordinary
shares in Genus on 11 September 2024 on the London Stock Exchange, to offset
income tax and social security liabilities due on the exercises and retained
the balance of ordinary shares.
Conditional nil-cost options granted under the PSP were subject to relevant
performance conditions, measured over a three-year performance period which
commenced on 1 July 2020 and ended on 30 June 2023. Following assessment of
the performance conditions, the Remuneration Committee determined that the
awards would vest at 36% of the original grant and the balance of the awards
have lapsed.
The below notifications, made in accordance with Article 19 of the Market
Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of
the European Union (Withdrawal) Act 2018, give further detail of the nil-cost
option awards made, exercised and ordinary shares sold on 11 September 2024.
For further information please contact:
Genus:
Cara Guedeney, Deputy Company
Secretary
Tel: +44 (0)1256 347100
Table A - GELT 2019 Performance Share Plan Options
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name 1. Jorgen Kokke
2. Alison Henriksen
3. Matt Culbertson
4. Jim Low
5. Jerry Thompson
6. Elena Rice
7. Angelle Rosata
8. Dan Hartley
2. Reason for the notification
a. Position/status 1. Chief Executive
2. Chief Financial Officer
3. Chief Operating Officer, Genus PIC
4. Chief Operating Officer, Genus ABS
5. Regional Director of ABS EMEA
6. Chief Scientific Officer
7. Chief Human Resources Officer
8. Group General Counsel & Company Secretary
b. Initial notification Initial notification
/Amendment
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Genus plc
b. LEI 54930022EOITNKSIGH56
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Ordinary shares of 10p each.
Financial instrument, type of instrument
Identification code
GB0002074580
b. Nature of the transaction Award of nil-cost share options granted under the PSP over ordinary shares in
Genus.
c. Price(s) and volume(s) Numbers 1 to 8 in the left-hand column correspond to the relevant PDMR as
detailed in boxes 1a and 2a above.
Price(s) Volume(s)
1. 0p 73,251
2. 0p 53,705
3. 0p 30,491
4. 0p 26,572
5. 0p 25,452
6. 0p 26,713
7. 0p 24,203
8. 0p 25,510
d. Aggregated information
· Aggregated volume
· Price n/a
e. Date of the transaction 2024-09-11
f. Place of the transaction Outside a trading venue.
d.
Aggregated information
· Aggregated volume
· Price
n/a
e.
Date of the transaction
2024-09-11
f.
Place of the transaction
Outside a trading venue.
Table B - GELT 2019 Deferred Share Bonus Plan Options
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name 1. Jorgen Kokke
2. Alison Henriksen
3. Matt Culbertson
4. Jim Low
5. Jerry Thompson
6. Elena Rice
7. Angelle Rosata
8. Dan Hartley
2. Reason for the notification
a. Position/status 1. Chief Executive
2. Chief Financial Officer
3. Chief Operating Officer, Genus PIC
4. Chief Operating Officer, Genus ABS
5. Regional Director of ABS EMEA
6. Chief Scientific Officer
7. Chief Human Resources Officer
8. Group General Counsel & Company Secretary
b. Initial notification Initial notification
/Amendment
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Genus plc
b. LEI 54930022EOITNKSIGH56
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Ordinary shares of 10p each.
Financial instrument, type of instrument
Identification code
GB0002074580
b. Nature of the transaction Award of nil-cost share options granted under the DSBP following the
compulsory deferral of 33% and 25% of annual bonus for Executive Directors and
members of GELT respectively in respect of bonuses earned in the financial
year ended 30 June 2024.
c. Price(s) and volume(s) Numbers 1 to 8 in the left-hand column correspond to the relevant PDMR as
detailed in boxes 1a and 2a above.
Price(s) Volume(s)
1. 0p 11,856
2. 0p 7,910
3. 0p 2,577
4. 0p 664
5. 0p 1,673
6. 0p 2,161
7. 0p 2,006
8. 0p 2,200
d. Aggregated information
· Aggregated volume
· Price n/a
e. Date of the transaction 2024-09-11
f. Place of the transaction Outside a trading venue.
d.
Aggregated information
· Aggregated volume
· Price
n/a
e.
Date of the transaction
2024-09-11
f.
Place of the transaction
Outside a trading venue.
Table C - GELT 2019 Performance Share Plan Exercise
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name Elena Rice
2. Reason for the notification
a. Position/status Chief Scientific Officer
b. Initial notification Initial notification
/Amendment
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Genus plc
b. LEI 54930022EOITNKSIGH56
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Ordinary shares of 10p each
Financial instrument, type of instrument
Identification code
GB0002074580
b. Nature of the transaction Exercise of nil-cost options under the PSP.
c. Price(s) and volume(s)
Price(s) Volume(s)
0p 3,996
d. Aggregated information Price(s) Volume(s)
0p 3,996
· Aggregated volume
· Price
e. Date of the transaction 2024-09-11
f. Place of the transaction Outside a trading venue.
5. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Ordinary shares of 10p each
Financial instrument, type of instrument
Identification code
GB0002074580
b. Nature of the transaction Sale of shares arising from the exercise of nil-cost options under the PSP to
offset income tax and social security liabilities due on the exercise.
c. Price(s) and volume(s)
Price(s) Volume(s)
1,853.94p 1,443
d. Aggregated information
Price(s) Volume(s)
· Aggregated volume 1,853.94p 1,443
· Price
e. Date of the transaction 2024-09-11
f. Place of the transaction London Stock Exchange, Main Market (XLON)
d.
Aggregated information
· Aggregated volume
· Price
Price(s) Volume(s)
0p 3,996
e.
Date of the transaction
2024-09-11
f.
Place of the transaction
Outside a trading venue.
5.
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a.
Description of the
Financial instrument, type of instrument
Identification code
Ordinary shares of 10p each
GB0002074580
b.
Nature of the transaction
Sale of shares arising from the exercise of nil-cost options under the PSP to
offset income tax and social security liabilities due on the exercise.
c.
Price(s) and volume(s)
Price(s) Volume(s)
1,853.94p 1,443
d.
Aggregated information
· Aggregated volume
· Price
Price(s) Volume(s)
1,853.94p 1,443
e.
Date of the transaction
2024-09-11
f.
Place of the transaction
London Stock Exchange, Main Market (XLON)
Table D - GELT Deferred Share Bonus Plan Exercise
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name Elena Rice
2. Reason for the notification
a. Position/status Chief Scientific Officer
b. Initial notification Initial notification
/Amendment
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Genus plc
b. LEI 54930022EOITNKSIGH56
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Ordinary shares of 10p each
Financial instrument, type of instrument
Identification code
GB0002074580
b. Nature of the transaction Exercise of nil-cost options under the DSBP.
c. Price(s) and volume(s)
Price(s) Volume(s)
0p 1,696
d. Aggregated information Price(s) Volume(s)
0p 1,696
· Aggregated volume
· Price
e. Date of the transaction 2024-09-11
f. Place of the transaction Outside a trading venue.
5. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Ordinary shares of 10p each
Financial instrument, type of instrument
Identification code
GB0002074580
b. Nature of the transaction Sale of shares arising from the exercise of nil-cost options under the DSBP to
offset income tax and social security liabilities due on the exercise.
c. Price(s) and volume(s)
Price(s) Volume(s)
1,853.92p 613
d. Aggregated information
Price(s) Volume(s)
· Aggregated volume 1,853.92p 613
· Price
e. Date of the transaction 2024-09-11
f. Place of the transaction London Stock Exchange, Main Market (XLON)
d.
Aggregated information
· Aggregated volume
· Price
Price(s) Volume(s)
0p 1,696
e.
Date of the transaction
2024-09-11
f.
Place of the transaction
Outside a trading venue.
5.
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a.
Description of the
Financial instrument, type of instrument
Identification code
Ordinary shares of 10p each
GB0002074580
b.
Nature of the transaction
Sale of shares arising from the exercise of nil-cost options under the DSBP to
offset income tax and social security liabilities due on the exercise.
c.
Price(s) and volume(s)
Price(s) Volume(s)
1,853.92p 613
d.
Aggregated information
· Aggregated volume
· Price
Price(s) Volume(s)
1,853.92p 613
e.
Date of the transaction
2024-09-11
f.
Place of the transaction
London Stock Exchange, Main Market (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHUUVVRSRUKAARRecent news on Genus
See all newsREG - Genus - Annual Report and Annual General Meeting
AnnouncementREG - Genus - Director/PDMR Shareholding
AnnouncementREG - Genus - Director/PDMR Shareholding
AnnouncementREG - Genus - Director/PDMR Shareholding
AnnouncementREG - Genus - Director/PDMR Shareholding
Announcement